Patents
Patents for C07C 259 - Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups (4,411)
12/2007
12/12/2007CN101087601A Compounds for inhibiting copper-containing amine oxidases and uses thereof
12/05/2007EP1861356A1 Imines as ion channel modulators
12/05/2007EP1638544B1 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions
11/2007
11/28/2007CN100351228C Hydroxamic acid derivatives and the method for preparing thereof
11/21/2007EP1856035A1 Process for preparaing protected amiidines
11/21/2007CN100349860C Prepn. of fatty hydroxamate
11/15/2007WO2007056469A3 Certain chemical entities, compositions, and methods
11/15/2007US20070265323 Compounds for the treatment of metabolic disorders
11/15/2007US20070265322 Compounds for the treatment of metabolic disorders
11/14/2007EP1381355B1 Use of rhein and its derivatives as matrix metalloproteinase inhibitors
11/08/2007US20070258972 Combination of a Histone Deacetylase Inhibitor with a Death Receptor Ligand
11/06/2007US7291728 Spirolactams and their synthesis
11/06/2007US7291617 Arylamidine derivative or salt thereof
11/01/2007WO2007077240A3 Functionalised nanoparticles, their production and use
10/2007
10/31/2007EP1318980B1 Hydroxamate derivatives useful as deacetylase inhibitors
10/31/2007EP1246795B1 Antibacterial agents
10/30/2007US7288567 Inhibitors of histone deacetylase
10/30/2007US7288566 Inhibit 20-hydroxyeicosatetraenoic acid (20-HETE)-producing enzymes; kidney disease
10/25/2007US20070249719 Compounds for the treatment of metabolic disorders
10/25/2007US20070249696 Compounds for the treatment of metabolic disorders
10/24/2007CN100344616C Compounds for the treatment of metabolic disorders
10/18/2007US20070244197 Bactericide against gramnegative bacteria; respiratory system disorders
10/18/2007US20070244172 Compounds for the treatment of metabolic disorders
10/18/2007US20070244171 Compounds for the treatment of metabolic disorders
10/18/2007US20070244141 Compounds for the treatment of metabolic disorders
10/18/2007US20070244117 Novel Hydroxamic Acid Esters and Pharmaceutical Use Thereof
10/16/2007US7282522 Anti-aging skin care; e.g. N-[4-(N-hydroxycarbamoyl)phenyl]benzamide; inhibits collagenase and/or elastase expression; less skin irritation than conventional retinoic acid
10/11/2007WO2007113644A2 New hdac inhibitors
10/11/2007WO2007072179A3 Histone deacetylase inhibitors for enhancing activity of antifungal agents
10/11/2007WO2007005603A3 Novel hydroxamic acid-containing amino acid derivatives
10/09/2007US7279601 Optically active α-aminooxyketone derivatives and process for production thereof
10/09/2007US7279478 Cathepsin cysteine protease inhibitors
10/03/2007CN100340545C Tetralone derivatives as antitumor agents
10/02/2007US7276612 For hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides
09/2007
09/27/2007US20070225373 Zn2Motif-Tethered Short-Chain Fatty Acids as a Novel Class of Histone Deacetylase
09/25/2007US7273863 Benzophenones as inhibitors of reverse transcriptase
09/19/2007CN101039905A New histone deacetylases inhibitors
09/18/2007USRE39850 Aryl amide, -sulfonamide, or -urea derivatives; antiproliferative, antitumor, anticarcinogenic, and/or antimetastasis agents
09/11/2007CA2254066C Compounds with anti-inflammatory and immunosuppressive activities
09/05/2007CN101031541A 4-aminomethyl benzamidine derivatives and their use as factor viia inhibitors
09/04/2007US7265220 Amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
08/2007
08/23/2007US20070197550 Histone deacetylase inhibitors for enhancing activity of antifungal agents
08/22/2007CN1332939C Novel compounds inhibiting factor Xa activity
08/21/2007CA2304965C ((cyclo)alkyl substituted)-gamma-aminobutyric acid derivatives (=gaba analogues), their preparation and their use in the treatment of neurological disorders
08/15/2007CN101018547A 组蛋白脱乙酰基酶抑制剂 Histone deacetylase inhibitors
08/08/2007EP1814850A1 New histone deacetylases inhibitors
08/01/2007CN101010298A Histone deacetylase inhibitor prodrugs
07/2007
07/26/2007US20070173542 Peptide deformylase inhibitors
07/19/2007WO2007009083A3 Compounds with activity at retinoic acid receptors
07/17/2007CA2432643C 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors
07/12/2007WO2007008994A3 Glutamate aggrecanase inhibitors
07/12/2007CA2636326A1 Functionalised nanoparticles, their production and use
07/11/2007CN1997626A Inhibitors of histone deacetylase
07/11/2007CN1997625A 组蛋白脱乙酰基酶抑制剂 Histone deacetylase inhibitors
07/10/2007US7241921 hydroxamic acid and N-formyl hydroxylamine compounds which inhibit the activity of the bacterial enzyme known as peptide deformylase
07/10/2007CA2308850C Inhibitors of gap junction communication
07/04/2007EP1581484B1 Hydroxamic acid derivatives having anti-inflammatory action
07/03/2007US7238339 Chelate metal ions that can be detected either by their paramagnetic or radioactive properties; diagnostic and therapeutic agents
06/2007
06/28/2007WO2007072179A2 Histone deacetylase inhibitors for enhancing activity of antifungal agents
06/28/2007US20070149516 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide
06/28/2007CA2633010A1 Histone deacetylase inhibitors for enhancing activity of antifungal agents
06/27/2007EP1799639A1 Novel dipeptidyl peptidase iv inhibitors, pharmaceutical compositions containing them, and process for their preparation
06/26/2007US7235689 Hydroxamic acid derivatives having anti-inflammatory action
06/21/2007US20070142635 Process for preparing hexahydropyrimido[1,2-a]azepine-2-carboxylates and related compounds
06/20/2007EP1796681A2 Compounds for inhibiting copper-containing amine oxidases and uses thereof
06/19/2007US7232929 Amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid
06/14/2007US20070135353 Crystalline n-formyl hydroxylamine compounds
06/13/2007CN1980886A Alpha-amino acid derivatives with antiinflammatory activity
06/12/2007CA2354023C Phenylglycine derivatives
06/07/2007US20070129368 Tricyclic hydroxamate and benzamide derivatives, compositions and methods
06/06/2007EP1792624A1 Modified amino acids and compositions comprising them for delivering active agents
06/06/2007EP1791810A1 4-aminomethyl benzamidine derivatives and their use as factor viia inhibitors
05/2007
05/31/2007US20070123493 Benzamide derivative
05/30/2007EP1789381A2 Inhibitors of histone deacetylase
05/22/2007US7220780 Naaladase inhibitors for treating retinal disorders and glaucoma
05/18/2007WO2007056469A2 Certain chemical entities, compositions, and methods
05/18/2007WO2006097279A8 Amidrazone compounds for combating animal pests
05/10/2007WO2007051408A1 Compounds for preventing or treating the h.pylori infection, preparation methods and use therrof
05/10/2007US20070105958 Compounds for the treatment of metabolic disorders
05/10/2007US20070105905 Novel macrocycles for the treatment of cancer
05/10/2007US20070105859 4-Phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (mek) inhibitors
05/09/2007EP1781714A1 Hydroxyamate-containing materials for the inhibition of matrix metalloproteinases
05/08/2007US7214714 for treatment of renal diseases, cerebrovascular diseases and circulatory diseases
05/08/2007US7214694 Controlling transforming growth facor; artificial skin; wound healing agents
05/03/2007WO2006128121A3 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
05/02/2007EP1780197A1 5-substituted-2-phenylamino-benzamide as mek inhibitor
04/2007
04/26/2007US20070093675 reacting an oxalic acid diester and an N-alkyl-O-alkylhydroxylamine in the presence of a base; uses safe starting materials, requires no complicated operation
04/25/2007CN1951912A Chiral alicyclic hydrocarbon hydroxamic acid derivative preparation method
04/19/2007WO2007024869A3 Catalyst for making fluoroelastomer compositions and methods of using the same
04/19/2007US20070088067 Novel amidine compounds for treating microbial infections
04/18/2007CN1310904C Tricyclic alkylhydroxamates, their preparation and thier use as well proliferation inhibitors
04/17/2007CA2190765C Novel potent inducers of terminal differentiation and methods of use thereof
04/11/2007EP1771167A2 Histone deacetylase inhibitors
04/10/2007CA2336380C Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof
04/04/2007CN1939898A Chiral synthesis of combined protein deacetylated enzyme inhibitor
03/2007
03/22/2007WO2007031213A1 Dioxazine- and oxadiazine-substituted arylamides
03/21/2007EP1763507A2 Alpha-amino acid derivates with antiinflammatory activity
03/21/2007EP0817643B1 Compounds and compositions for delivering active agents
03/21/2007CN1305839C Phenylglycine derivatives
03/15/2007WO2007001211A3 Dicarbonic acid derivatives, metastasis inhibitors and agents increasing chemotherapeutic activity of anti-tumor preparations, method for enhancing the cytostatic efficiency and metastasis process inhibiting method
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... 45